Centessa Pharmaceuticals PLC (CNTA)
15.98
+0.08
(+0.53%)
USD |
NASDAQ |
Nov 05, 16:00
15.98
0.00 (0.00%)
After-Hours: 20:00
Centessa Pharmaceuticals Net Income (Quarterly): -43.82M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -43.82M |
| March 31, 2024 | -38.05M |
| December 31, 2023 | -36.84M |
| September 30, 2023 | -38.65M |
| June 30, 2023 | -24.89M |
| March 31, 2023 | -50.71M |
| December 31, 2022 | -43.17M |
| Date | Value |
|---|---|
| September 30, 2022 | -53.88M |
| June 30, 2022 | -64.66M |
| March 31, 2022 | -54.50M |
| December 31, 2021 | |
| September 30, 2021 | -40.16M |
| June 30, 2021 | -41.45M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-64.66M
Minimum
Jun 2022
-24.89M
Maximum
Jun 2023
-44.23M
Average
-42.31M
Median
Net Income (Quarterly) Benchmarks
| Biodexa Pharmaceuticals PLC | -- |
| Verona Pharma PLC | -70.84M |
| Autolus Therapeutics PLC | -58.27M |
| Mereo BioPharma Group PLC | -12.26M |
| Achilles Therapeutics PLC | -16.38M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 43.98M |
| EPS Diluted (Quarterly) | -0.40 |
| Enterprise Value | 1.826B |
| Earnings Yield | -9.70% |